Related Experiment Video

Updated: Jun 18, 2025

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

840

Sphingolipid metabolism and regulated cell death in malignant melanoma

Kexin Yan1, Wei Zhang1, Hao Song2

  • 1Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China.

Apoptosis : an International Journal on Programmed Cell Death
|July 28, 2024
PubMed

Insights

Sphingolipids (SP) are bioactive lipids that regulate programmed cell death in malignant melanoma (MM). Understanding SPs’ role in apoptosis, necroptosis, and ferroptosis is key to developing new melanoma treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Malignant melanoma (MM) is an aggressive skin cancer with limited treatment options.
  • Programmed cell death is critical in MM development and progression.
  • Sphingolipids (SP) are bioactive lipids implicated in various diseases.

Purpose of the Study:

  • To review the mechanisms by which sphingolipids modulate programmed cell death in malignant melanoma.
  • To explore the role of SPs in apoptosis, necroptosis, and ferroptosis in MM.
  • To highlight the therapeutic potential of targeting SPs in melanoma treatment.

Main Methods:

  • Literature review focusing on sphingolipid metabolism and programmed cell death pathways in MM.
  • Analysis of signaling pathways and cellular processes regulated by SPs in melanoma.
  • Synthesis of current knowledge on SPs' impact on MM cell survival and death.

Main Results:

  • Sphingolipids differentially regulate apoptosis, necroptosis, and ferroptosis in MM cells.
  • SPs influence cell membrane integrity and intracellular signaling cascades.
  • Specific SPs can promote or inhibit melanoma cell death depending on the context.

Conclusions:

  • Sphingolipids are key regulators of programmed cell death in malignant melanoma.
  • Targeting sphingolipid metabolism offers a promising avenue for novel MM therapies.
  • Further research into SPs' roles can elucidate melanoma pathogenesis and guide treatment strategies.
Keywords:
Malignant melanomaRegulated cell deathSphingolipid metabolism

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.7K
Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells10:33

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells

Published on: June 16, 2019

27.4K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K